Extraordinary General Meeting Convened for Stock Face Value Consolidation... Capital Restructuring with No Impact on Shareholder Value
From Bio has resolved to convene an extraordinary general meeting on July 6, 2026 at 10:00 AM at a seminar room in Suwon, Gyeonggi-do.
The main agenda items are 'Stock Face Value Consolidation' and 'Partial Amendment of Articles of Incorporation', following the stock consolidation decision disclosed on May 28, 2026.
The consolidation will combine existing shares at a certain ratio, reducing the number of shares while increasing the per-share price proportionally, with no change in capital or direct impact on shareholder value.
While the consolidation aims to stabilize the stock price and improve trading activity, it may be perceived negatively in the short term as a signal of undervaluation.
KOSDAQ Filing Information
Filing: Resolution to Convene a General Meeting of Shareholders (Extraordinary General Meeting)